p-chloroamphetamine- and d-fenfluramine-induced brain serotonin release in experimental portal-systemic encephalopathy

Metabolic Brain Disease

Volumn 12, Issue 3, 1997, Pages 229-236

  Bergqvist, Peter B F ^a,c   Hjorth, Stephan ^b   Wikell, Cecilia ^a   Apelqvist, Gustav ^a   Bengtsson, Finn ^a  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

d fenfluramine; Hepatics encephalopathy; p chloroamphetamine; Portacaval shunt; Release; Serotonin

Indexed keywords

CHLORAMPHETAMINE; FENFLURAMINE;

ANIMAL EXPERIMENT; ARTICLE; CHRONIC LIVER DISEASE; CONTROLLED STUDY; HEPATIC ENCEPHALOPATHY; LIVER FAILURE; MALE; NONHUMAN; PORTOCAVAL SHUNT; RAT; SEROTONIN BRAIN LEVEL; SEROTONIN RELEASE;

ANIMALS; BRAIN; CEREBRAL CORTEX; EXTRACELLULAR SPACE; FENFLURAMINE; HEPATIC ENCEPHALOPATHY; HYDROXYINDOLEACETIC ACID; MALE; OSMOLAR CONCENTRATION; P-CHLOROAMPHETAMINE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN AGENTS;

ANIMALIA; MARCHANTIOPHYTA;

EID: 0030821247     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:MEBR.0000007103.82267.06     Document Type: Article

References (23)

1. Adell, A., Sarna, G.S., Hutson, P.H., and Curzon, G. (1989). An in vivo dialysis and behavioural study of the release of 5-HT by p-chloroamphetamine in reserpine-treated rats. Br. J. Pharmacol. 97:206-212.
2. Bengtsson, F., Bugge, M., Brun, A., Falck, B., Henriksson, K.G., and Nobin, A. (1988). The impact of time after portacaval shunt in the rat on behavior, brain serotonin, and brain and muscle histology. J. Neurolog. Sci. 83:109-122.
3. Bengtsson, F., Bugge, M., and Nobin, A. (1989). Hepatocerebral dysfunction and brain serotonin. In (R.F. Butterworth, and G. Pomier Layrargues, eds.), Hepatic Encephalopathy: Pathophysiology and Treatment. Humana Press, Clifton, NJ, pp. 355-387.
4. Bengtsson, F. (1992). Neurotransmission failure in hepatic encephalopathy involving the combined action of different brain tryptophan-related pathology: a speculative synthesis. In (I, Ishiguro, T. Nagatsu, and Y. Nagamura, eds.), Advances in Tryptophan Research 1992. Fujita Health University Press, Toyoake, Japan, pp. 303-308.
5. Bengtsson, F., and Bergqvist, P.B.F. (1996). Neuropsychiatric implications of brain tryptophan: Perturbations appearing in hepatic encephalopathy. In (G.A. Filippini, C.V.L. Costa, and A. Bertazzo, eds.), Recent Advances in Tryptophan Research. Plenum, New York, NY, pp. 387-395.
6. Bergqvist, P.B.F., Vogels, B.A.P.M., Bosman, D.K., Maas, M.A.W., Hjorth, S., Chamuleau, R.A.F.M., and Bengtsson, F. (1995). Neocortical dialysate monoamines of rats after acute, subacute, and chronic liver shunt. J. Neurochem. 64:1238-1244.
7. Bergqvist, P.B.F., Hjorth, S., Apelqvist, G., and Bengtsson, F. (1996a). Acute effects of L-tryptophan on brain extracellular 5-HT and 5-HIAA levels in chronic experimental portal-systemic encephalopathy. Metab. Brain Dis. 11:269-278.
8. Bergqvist, P.B.F., Hjorth, S., Audet, R., Apelqvist, G., Bengtsson, F., and Butterworth R.F. (1996b). Ammonium acetate challenge in experimental hepatic encephalopathy induces a transient increase of brain 5-HT release in vivo. Eur. Neuropsychopharmacology 6:317-324.
9. Bergqvist, P.B.F., Hjorth, S., Apelqvist, G., and Bengtsson, F. (1997). Potassium-evoked neuronal release of serotonin in experimental chronic portal-systemic encephalopathy. Metab. Brain Dis. 12:185-194.
10. Bergqvist, P.B.F., and Bengtsson, F. (1997). Brain tryptophan-related perturbations in hepatic encephalopathy: an update. In (R. Richard, ed.), Current Topics in Neurochemistry, Research Trends, Trivandrum, India, In press.
11. Bonanno, G., Fassio, A., Severi, P., Ruelle, A., and Raiteri, M. (1994). Fenfluramine releases serotonin from human brain nerve endings by a dual mechanism. J. Neurochem. 63:1163-1166.
12. de Parada, M.P., Parada, M.A., Pothos, E., and Hoebel B.G. (1995). d-Fenfluramine, but not d-norfenfluramine, uses calcium to increase extracellular serotonin. Life Sci. 56:415-420.
13. Fuller, R.W., Hines, C.W., and Mills, J. (1965). Lowering of brain serotonin level by chloroamphetamines. Biochem. Pharmacol. 14:483-488.
14. Garattini, S., Caccia, S., Mennini, T., Samanin, R., Consolo, S., and Ladinsky, H. (1979). Biochemical pharmacology of the anorectic drug fenfluramine: a review. Curr. Med. Res. Opin. 6(suppl1):15-27.
15. Hjorth, S., and Sharp, T. (1993). In vivo microdialysis evidence for central serotonin1A and serotonin1B autoreceptor blocking properties of the beta adrenoceptor antagonist (-)penbutolol. J. Pharmacol. Exp. Ther. 265:707-712.
16. Kuhn, D.M., Wolf, W.A., and Youdim, M.B.H. (1985). 5-Hydroxytryptamine release in vivo from a cytoplasmic pool: studies on the 5-HT behavioural syndrome in reserpinized rats. Br. J. Pharmacol. 84:121-129.
17. Lee, S.H., and Fisher, B. (1961). Portacaval shunt in the rat. Surgery 50:668-672.
18. Mans, A.M., DeJoseph, M.R., Davis, D.W., Vina, J.R., and Hawkins, R.A. (1990). Early establishment of cerebral dysfunction after portacaval shunting. Am. J. Physiol. 259:E104-E-110.
19. Mousseau, D.D., and Butterworth, R.F. (1994). Current theories on the pathogenesis of hepatic encephalopathy. Exp. Biol. Med. 206:329-344.
20. Schröder, R., Müller, O., and Bircher, J. (1985). The portacaval and splenocaval shunt in the normal rat. A morphometric and functional reevaluation. J. Hepatol. 1:107-123.
21. Swain, M.S., Blei, A.T., Butterworth, R.F., and Kraig, R.P. (1991). Intracellular pH rises and astrocytes swell after portacaval anastomosis in rats. Regulatory Intergrative Comp. Physiol. 30:R1491-R1496.
22. Trulson, M.E., and Jacobs, B.L. (1976). Behavioral evidence for the rapid release of CNS serotonin by PCA and fenfluramine. Eur. J. Pharmacol. 36:149-154.
23. Wichems, C.H., Hollingsworth, C.K., and Bennett, B.A. (1995). Release of serotonin induced by 3,4-methylenedioxymethamphetamine (MDMA) and other substituted amphetamines in cultured fetal raphe neurons: further evidence for calcium-independent mechanisms of release. Brain Res. 695:10-18.